Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Vertex Pharmaceuticals (NQ: VRTX ) 469.76 +4.68 (+1.01%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 1,128,879 Open 472.00 Bid (Size) 454.51 (1) Ask (Size) 469.76 (1) Prev. Close 465.08 Today's Range 461.36 - 472.31 52wk Range 341.85 - 510.63 Shares Outstanding 259,428,394 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News What Analysts Are Saying About Vertex Pharmaceuticals Stock Today 8:01 EDT Via Benzinga Pfizer Tanked A $5.4 Billion Takeover. Why Crispr, Agios, Beam Could Benefit. September 26, 2024 Pfizer stock dipped Thursday after the company voluntarily pulled its sickle cell drug, Oxbryta, from the market following patient deaths. Via Investor's Business Daily Performance YTD +14.32% +14.32% 1 Month -1.25% -1.25% 3 Month -0.85% -0.85% 6 Month +14.74% +14.74% 1 Year +35.03% +35.03% More News Read More Vertex Highlights First Oral Presentation of Phase 3 Clinical Data of the Vanza Triple and New Data on Long-Term Impact of TRIKAFTA® at the North American Cystic Fibrosis Conference September 26, 2024 From Vertex Pharmaceuticals Incorporated Via Business Wire If You Invested $100 In This Stock 15 Years Ago, You Would Have $1,200 Today September 25, 2024 Via Benzinga Demystifying Vertex Pharmaceuticals: Insights From 16 Analyst Reviews September 19, 2024 Via Benzinga Looking Into Vertex Pharmaceuticals's Recent Short Interest September 18, 2024 Via Benzinga Vertex Pharmaceuticals's Options Frenzy: What You Need to Know August 29, 2024 Via Benzinga The Best Biotech Stock to Invest $1,000 in Right Now September 22, 2024 Via The Motley Fool Bull Market and Beyond: 2 Stocks Just Waiting to Soar September 21, 2024 Via The Motley Fool Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030 September 18, 2024 Via The Motley Fool 3 Stocks to Buy and Hold Forever September 14, 2024 Via The Motley Fool Prediction: These 3 Phenomenal Stocks Are Set to Soar September 14, 2024 Via The Motley Fool Time To Invest And Or Trade In Bio-Tech Stocks? September 13, 2024 Via Talk Markets Topics ETFs Looking Into Vertex Pharmaceuticals's Recent Short Interest August 27, 2024 Via Benzinga Unpacking the Latest Options Trading Trends in Vertex Pharmaceuticals August 23, 2024 Via Benzinga Biotech Breakout: Stocks for Your Watchlist September 12, 2024 Via MarketBeat Topics ETFs Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 20 Years September 06, 2024 Via Benzinga 3 No-Brainer Stocks to Buy in September August 31, 2024 Via The Motley Fool 3 Rock-Solid Pharma Stocks to Buy Now and Hold Forever August 30, 2024 Via The Motley Fool 3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow August 30, 2024 Via The Motley Fool If You Invested $100 In This Stock 20 Years Ago, You Would Have $4,900 Today August 21, 2024 Via Benzinga Biotech And Life Science Sector Update Summer Of 2024 August 29, 2024 Via Talk Markets Jim Cramer: 'Hold On' To Builders FirstSource, 'Here's The Problem' With Viking Therapeutics August 29, 2024 Via Benzinga Forget Novo Nordisk: Buy This Magnificent Pharma Stock Instead August 23, 2024 Via The Motley Fool Vertex to Participate in Upcoming September Investor Conferences August 22, 2024 From Vertex Pharmaceuticals Incorporated Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
